Skip to main content

Displaying 2381 - 2400 of 4733

In re Nexium (Esomeprazole) Antitrust Litigation

Date
Citation Number
15-2005, 15-2006, 15-2007
Federal Court
U.S. Circuit Court of Appeals for the First Circuit
Brief of the Federal Trade Commission arguing that the district court committed legal error by conflating two distinct analyses under antitrust law: the existence of an antitrust violation, which...

ArcLight Energy Partners Fund VI, L.P., In the Matter of

ArcLight Energy Partners Fund VI, L.P., agreed to divest its ownership interest in four light petroleum product terminals in Pennsylvania, to settle charges that ArcLight’s acquisition of Gulf Oil Limited Partnership from its parent company, Cumberland Farms, Inc., would likely be anticompetitive in three Pennsylvania terminal markets: Altoona, where ArcLight would own the only terminal handling gasoline and one of two terminals handling distillates; Scranton, where ArcLight would own one of two terminals handling gasoline and distillates; and Harrisburg, where ArcLight would own one of two terminals handling gasoline and one of three terminals handling distillates.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
151 0149
Docket Number
C-4563

Drug Testing Compliance Group, LLC, In the Matter of

Drug Testing Compliance Group, LLC, agreed to settle charges that it illegally invited one of its competitors to enter into a customer allocation agreement in violation of Section 5 of the FTC Act.  The proposed settlement prohibits DTC Group from communicating with competitors about rates or prices (although it does not bar public posting of rates). The settlement also prohibits the company from soliciting, entering into, or maintaining an agreement with any competitor to divide markets, allocate customers, or fix prices; and from urging any competitor to raise, fix, or maintain prices, or to limit or reduce service.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
151 0048

NXP Semiconductors N.V., In the Matter of

NXP Semiconductors N.V. agreed to sell its RF power amplifier assets in order to settle charges that its proposed $11.8 billion acquisition of Freescale Semiconductor Ltd. would substantially lessen competition in the worldwide market for RF power amplifiers, likely resulting in higher prices and reduced innovation. The proposed consent order preserves competition by requiring NXP to divest all its assets that are used primarily for manufacturing, research, and development of RF power amplifiers to the Chinese private equity firm Jianguang Asset Management Co. Ltd. These assets include a manufacturing facility in the Philippines, a building in the Netherlands to house management and some testing labs, as well as all patents and technologies used exclusively or predominantly for the RF power amplifier business, and a royalty-free license to use all other NXP patents and technologies required by that business. The divestiture also includes all of NXP’s RF power amplifier employees and managers.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
151 0090